Article Text

Download PDFPDF
Letter
Neurodevelopmental outcomes with congenital ocular motor apraxia
  1. A Paula Grigorian1,
  2. Katherine J Fray1,
  3. Michael C Brodsky2,
  4. Paul H Phillips1
  1. 1University of Arkansas Medical Center and Arkansas Children's Hospital, Little Rock, Arkansas, USA
  2. 2Mayo Clinic, Rochester, Minnesota, USA
  1. Correspondence to Dr Paul H Phillips, Arkansas Children's Hospital, 1 Children's Way, Little Rock, AR 72202, USA; phillipspaulh{at}uams.edu

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The unique ocular motility dysfunction in isolated congenital ocular motor apraxia (COMA) is well characterised.1 Clinical findings include difficulty initiating horizontal saccades, horizontal head thrusting and relative preservation of vertical eye movements. In the European literature, COMA is referred to as Horizontal Saccadic Initiation Failure.2

Previous investigators have described the ocular motility dysfunction in patients with COMA.2 However, the neurodevelopmental profile of these patients has not been systematically investigated.3 The purpose of this study is to characterise the neurodevelopmental outcome in patients with COMA.

Methods

We retrospectively analysed the medical records of all children diagnosed with COMA at Arkansas Children's Hospital between 1993 and 2007. These patients were identified from a database that includes the diagnosis of all patients evaluated in the ophthalmology clinic during this time interval. Each patient had a complete ophthalmological examination as well as a developmental history, including questions regarding motor coordination, gait, language development, intellectual ability and school performance. The developmental status was determined from a review of the medical records from the ophthalmology clinic and …

View Full Text

Footnotes

  • A supplementary table is published online only at http://bjo.bmj.com/content/vol94/issue2

  • Funding Supported in part by an unrestricted grant from Research to Prevent Blindness (New York, NY) and the Pat & Willard Walker Eye Research Center, Jones Eye Institute, University of Arkansas for Medical Sciences (Little Rock, AR).

  • Competing interests None.

  • Ethics approval Ethics approval was provided by the University of Arkansas for Medical Sciences (UAMS) IRB.

  • Provenance and peer review Not commissioned; externally peer reviewed.